Randomized Phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer.

Aurélie Cabrespine; Laurent Guy; Elhani Khenifar; Hervé Curé; Joël Fleury; Frédérique Penault-Llorca; Fabrice Kwiatkowski; Chantal Barthomeuf; Philippe Chollet; Jacques-Olivier Bay

doi:10.1016/j.urology.2005.08.046

Randomized Phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer.

Identifier:nobleid.org/w1/20260515/D2DF7060

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D2DF7060.svg?ark=w1%2F20260515%2FD2DF7060)](https://nobleid.org/work/w1/20260515/D2DF7060)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Frédérique Penault-Llorca

Claim authorship of this work

Randomized Phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer.

Identifier:nobleid.org/w1/20260515/D2DF7060

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D2DF7060.svg?ark=w1%2F20260515%2FD2DF7060)](https://nobleid.org/work/w1/20260515/D2DF7060)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Frédérique Penault-Llorca

Claim authorship of this work